| Literature DB >> 31892177 |
Daniel Gomes1,2, Ana Isabel Placido1, Rita Mó3, João Lindo Simões4, Odete Amaral5, Isabel Fernandes1, Fátima Lima6, Manuel Morgado1,3,7,8, Adolfo Figueiras9,10, Maria Teresa Herdeiro11, Fátima Roque1,8.
Abstract
The presence of age-related comorbidities prone elderly patients to the phenomenon of polypharmacy and consequently to a higher risk of nonadherence. Thus, this paper aims to characterize the medication consumption profile and explore the relationship of beliefs and daily medication management on medication adherence by home-dwelling polymedicated elderly people. A questionnaire on adherence, managing, and beliefs of medicines was applied to polymedicated patients with ≥65 years old, in primary care centers of the central region of Portugal. Of the 1089 participants, 47.7% were considered nonadherent. Forgetfulness (38.8%), difficulties in managing medication (14.3%), concerns with side effects (10.7%), and the price of medication (9.2%) were pointed as relevant medication nonadherence-related factors. It was observed that patients who had difficulties managing medicines, common forgetfulness, concerns with side effects, doubting the need for the medication, considered prices expensive, and had a lack of trust for some medicines had a higher risk of being nonadherent. This study provides relevant information concerning the daily routine and management of medicines that can be useful to the development of educational strategies to promote health literacy and improve medication adherence in polymedicated home-dwelling elderly.Entities:
Keywords: daily management of medication; elderly; medication adherence; nonadherence related factors; polypharmacy; self-care
Mesh:
Year: 2019 PMID: 31892177 PMCID: PMC6981635 DOI: 10.3390/ijerph17010200
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Socio-demographic characteristics of the participants.
| % ( | |
|---|---|
|
| |
| Female | 62.6% (680) |
| Male | 37.4% (407) |
|
| |
| (65–68) | 11.2% (121) |
| (68–71) | 15.1% (163) |
| (71–74) | 13.1% (141) |
| (74–77) | 15.8% (170) |
| (77–80) | 11.8% (127) |
| (80–83) | 12.0% (130) |
| (83–86) | 10.4% (112) |
| (86–89) | 6.0% (65) |
| (89–92) | 2.9% (31) |
| (92–95) | 1.1% (12) |
| (95–99) | 0.6% (7) |
|
| |
| <439 EUR | 58.8% (579) |
| 440–580 EUR | 23.6% (232) |
| 581–1160 EUR | 14.7% (145) |
| ≥1161 EUR | 2.9% (29) |
|
| |
| Alone | 27.0% (294) |
| Partner | 60.1% (654) |
| Son and/or Grandchildren | 8.5% (93) |
| Others | 3.3% (35) |
|
| |
| Does not read or write | 7.7% (83) |
| Knows how to read/write but no grade | 15.8% (171) |
| Primary School | 57.7% (626) |
| 2° Cycle (5th and 6th grade) | 7.0% (76) |
| 3° Cycle (7th to 9th) | 4.8% (52) |
| High School (10th to 12th) | 3.5% (38) |
| Medium grade | 0.8% (9) |
| Higher Education/Graduate | 2.7% (29) |
|
| |
| Interior | 70.5% (768) |
| Coast | 29.5% (321) |
Consumption of medicines from the fourth level pharmacological groups of Group A, Group C, and Group N.
| % ( | |
|---|---|
| Group A | |
| A01A stomatological preparations | 0.2% (2) |
| A02A antacids | 0.3% (3) |
| A02B drugs for peptic ulcer and gastro-oesophageal reflux disease | 46.4% (501) |
| A03A drugs for functional gastrointestinal disorders | 1.2% (13) |
| A03B belladonna and derivatives, plain | 0.3% (3) |
| A03F propulsives | 2.1% (23) |
| A05A bile therapy | 0.1% (1) |
| A06A drugs for constipation | 1.3% (14) |
| A07A intestinal antiinfectives | 0.1% (1) |
| A07D antipropulsives | 0.3% (3) |
| A07E intestinal antiinflammatory agents | 0.7% (8) |
| A07F antidiarrheal microorganisms | 0.2% (2) |
| A09A digestives, incl. Enzymes | 0.4% (4) |
| A10A insulins and analogues | 7.6% (83) |
| A10B blood glucose lowering drugs, excl. Insulins | 37.3% (403) |
| A11A multivitamins, combinations | 0.1% (1) |
| A11C vitamin a and d, incl. Combinations of the two | 4.8% (52) |
| A11D vitamin b1, plain and in combination with vitamin b6 and b12 | 1.7% (18) |
| A11E vitamin b-complex, incl. Combinations | 0.3% (3) |
| A11G ascorbic acid (vitamin c), incl. Combinations | 0.1% (1) |
| A12A calcium | 6.4% (69) |
| A12C other mineral supplements | 1.6% (17) |
| A13A tonics | 0.1% (1) |
| Group C | |
| C01A cardiac glycosides | 2.3% (25) |
| C01B antiarrhythmics, class i and iii | 3.9% (42) |
| C01D vasodilators used in cardiac diseases | 4.9% (53) |
| C01E other cardiac preparations | 5.8% (62) |
| C02A antiadrenergic agents, centrally acting | 1.9% (20) |
| C02C antiadrenergic agents, peripherally acting | 0.2% (2) |
| C03A low-ceiling diuretics, thiazides | 0.2% (2) |
| C03B low-ceiling diuretics, excl. Thiazides | 9.2% (99) |
| C03C high-ceiling diuretics | 18.7% (201) |
| C03D potassium-sparing agents | 3.2% (35) |
| C03E diuretics and potassium-sparing agents in combination | 1.6% (17) |
| C04A peripheral vasodilators | 3.2% (35) |
| C05A agents for treatment of hemorrhoids and anal fissures for topical use | 0.2% (2) |
| C05B antivaricose therapy | 0.6% (6) |
| C05C capillary stabilizing agents | 7.2% (77) |
| C07A beta blocking agents | 26.7% (289) |
| C07B beta blocking agents and thiazides | 0.2% (2) |
| C07C beta blocking agents and other diuretics | 0.1% (1) |
| C08C selective calcium channel blockers with mainly vascular effects | 14.8% (159) |
| C08D selective calcium channel blockers with direct cardiac effects | 1.9% (20) |
| C08G calcium channel blockers and diuretics | 0.1% (1) |
| C09A angiotensin-converting-enzyme inhibitors, plain | 16.4% (176) |
| C09B angiotensin-converting-enzyme inhibitors, combinations | 14.5% (156) |
| C09C angiotensin II receptor blockers, plain | 18.3% (198) |
| C09D angiotensin II receptor blockers, combinations | 21.3% (230) |
| C09X other agents acting on the renin-angiotensin system | 0.2% (2) |
| C10A lipid modifying agents, plain | 59.7% (644) |
| C10B lipid modifying agents, combinations | 3.5% (38) |
| Group N | |
| N01A anesthetics, general | 0.2% (2) |
| N02A opioids | 8.2% (88) |
| N02B other analgesics and antipyretics | 13.2% (143) |
| N02C antimigraine preparations | 0.1% (1) |
| N03A antiepileptics | 9.3% (100) |
| N04B dopaminergic agents | 2.9% (31) |
| N05A antipsychotics | 4.5% (48) |
| N05B anxiolytics | 38.6% (406) |
| N05C hypnotics and sedatives | 4.6% (50) |
| N06A antidepressants | 22.4% (242) |
| N06B psychostimulants, agents used for adhd and nootropics | 2.6% (28) |
| N06D anti-dementia drugs | 4.3% (46) |
| N07A parasympathomimetics | 0.1% (1) |
| N07C antivertigo preparations | 8.1% (87) |
| N07X other nervous system drugs | 0.1% (1) |
Minimum, maximum, mean and median of the adherence levels.
| Minimum | Maximum | Mean ± SD | Median | |
|---|---|---|---|---|
|
| 300 ( | 6.00 ( | 5.47 ± 0.47 | 5.57 |
Results from the Questions of Adherence Treatment Measure (MAT) and respective Mean and Median.
| Always % ( | Almost Always % ( | Often % ( | Sometimes % ( | Seldom % ( | Never % ( | Mean ± SD | Median | |
|---|---|---|---|---|---|---|---|---|
| 1. Have you ever forgotten to take the medicines for your illness? | 0.1% (1) | 0.4% (4) | 3.1% (34) | 20.1% (219) | 45.4% (494) | 30.9% (336) | 5.03 ± 0.83 | 5 |
| 2. Have you ever been careless about the time you take your medicines? | 0.0% (0) | 0.7% (8) | 3.1% (34) | 20.7% (225) | 47.8% (521) | 27.6% (301) | 4.99 ± 0.82 | 5 |
| 3. Have you ever stopped taking medicines for your illness because you felt better? | 0.0% (0) | 0.2% (2) | 1.7% (19) | 8.2% (89) | 11.8% (128) | 78.1% (850) | 5.66 ± 0.72 | 6 |
| 4. Have you ever stopped taking the medicines for your illness on your own after feeling worse? | 0.1% (1) | 0.3% (3) | 1.6% (17) | 10.2% (111) | 12.9% (140) | 75.0% (814) | 5.60 ± 0.77 | 6 |
| 5. Have you ever taken one or more pills for your illness on your own after feeling worse? | 0.0% (0) | 0.1% (1) | 0.8% (9) | 3.8% (41) | 9.3% (101) | 86.0% (937) | 5.80 ± 0.54 | 6 |
| 6. Have you ever interrupted therapy for your illness because you have run out of medicines? | 0.0% (0) | 0.2% (2) | 1.0% (11) | 8.9% (97) | 18.8% (205) | 71.1% (774) | 5.60 ± 0.71 | 6 |
| 7. Have you ever stopped taking your medicines for some reason other than doctor′s appointment? | 0.0% (0) | 0.2% (2) | 0.9% (10) | 9.9% (108) | 12.6% (137) | 76.4% (832) | 5.64 ± 0.7 | 6 |
Frequencies on the reasons to not take the medication as prescribed.
| Sometimes You Do Not Take Your Medication Exactly as Your Doctor Has Prescribed Because: | % ( |
|---|---|
| a. Has difficulty managing so many medicines. | 14.3% (156) |
| b. Forgetfulness. | 38.8% (423) |
| c. Do not register as taking instructions. | 4.4% (48) |
| d. Concern with side effects. | 10.7% (116) |
| e. Hard to take. | 4.8% (52) |
| f. Doubt the need for the medication | 2.9% (32) |
| g. Price of medicines | 9.2% (100) |
| h. Not wanting to take medication and drink alcohol | 2.2% (24) |
| i. Not liking to take medications | 4.1% (45) |
| j. Do not trust some medications | 2.1% (23) |
| k. Interfere with social life | 3.3% (36) |
Spearman correlation between adherence level and age and medicines prescribed.
| Coefficient Value | Significance ( | ||
|---|---|---|---|
|
| Age | 0.077 | 0.018 |
| Medicines Prescribed | 0.082 | 0.031 | |
Factors influencing medication nonadherence.
| Independent Dichotomous Variables | OR [95% CI] * | Χ2 ( |
|---|---|---|
| Sometimes you do not take your medication exactly as your doctor has prescribed because: | ||
| Has difficulty managing so many medicines | 1.720 [95% CI 1.189–2.489] | 0.004 |
| Forgetfulness | 3.370 [95% CI 2.572–4.400] | <0.001 |
| Do not register as taking instructions | 1.552 [95% CI 0.835–2.885] | 0.161 |
| Concern with side effects | 3.555 [95% CI 2.248–5.626] | <0.001 |
| Hard to take | 1.717 [95% CI 0.919–3.208] | 0.087 |
| Doubt the need for the medication | 3.910 [95% CI 1.668–9.165] | 0.001 |
| Price of medicines expensive | 2.290 [95% CI 1.455–3.605] | <0.001 |
| Not wanting to take medication and drink alcohol | 0.379 [95% CI 0.148–0.969] | 0.036 |
| Not liking to take medications | 0.815 [95% CI 0.430–1.522] | 0.520 |
| Do not trust some medications | 5.090 [95% CI 1.711–15.163] | 0.001 |
| Interfere with social life | 1.328 [95% CI 0.661–2.667] | 0.424 |
| Sociodemographic characteristics | ||
| Female | 1.408 [95% CI 1.082–1.833] | 0.011 |
| Male | 0.710 [95% CI 0.546–0.924] | 0.011 |
| Living alone | 1.187 [95% CI 0.892–1.579] | 0.241 |
| Not having level of education | 1.196 [95% CI 0.889–1.608] | 0.237 |
| Living in the Interior Region of Centre Portugal | 2.506 [95% CI 1.874–3.351] | <0.001 |
| Earning <439 EUR | 1.701 [95% CI 1.314–2.203] | <0.001 |
* CI—Confidence Interval.